Donna Peratino took the same pulmonary hypertension medication for seven years. Then her insurance company stopped covering the brand version, and her symptoms worsened. Find out how Peratino pushed her insurance to cover the version of the drug that works best for her.
“Before the ACA, I watched the lifetime coverage cap very closely. My daughter with pulmonary hypertension (PH) and heart disease had used almost half her cap before the passage of the ACA, and she was a toddler. I didn't know what we'd do if she hit the cap, which she would have done in
Individuals impacted by pulmonary hypertension (PH) should contact their PH care team and specialty pharmacy if they anticipate changes in their health insurance in January. Even health insurance provided through the same carrier may alter coverage benefits in 2020. Health insurance companies may remove medications from plan formularies or institute new prior authorization requirements.
Dear PH Community, Here in Washington, D.C., autumn has arrived with some cooler weather and the first golden and orange leaves. Fall means that vacations are mostly over, and school is back in session. It also means that the complex process of open enrollment is almost upon us. The Pulmonary Hypertension Association (PHA) is
Questions to Consider When Choosing Between Brand and Generic Therapy Teva Pharmaceutical Industries recently announced the launch of ALYQ ™ (tadalafil), a generic version of the drug Adcirca®. Mylan launched the first generic tadalafil in August. How an individual with pulmonary hypertension (PH) is impacted by the availability of generic therapy may depend on
As of 1/2/2019, Medicare recipients with pulmonary hypertension can apply for a co-pay assistance grant up to $5,300 from the PAN Foundation. Phone lines will likely be crowded, so online applications are encourage. Apply online at https://www.panapply.org/ or call 1-866-316-7263 For a general list of co-pay assistance resources developed by the Pulmonary Hypertension Association, visit
Many individuals with pulmonary hypertension (PH) experience changes in their health insurance coverage or charitable assistance grants at the beginning of the year. In many cases, these changes mean that doctors’ offices and specialty pharmacies must take additional steps before prescriptions can be filled. Contact your PH doctor and specialty pharmacy now to reduce
Now is the time to renew health insurance coverage purchased through a state or federal health insurance marketplace, also known as an insurance exchange. Marketplace open enrollment has begun and continues through Dec. 15. The federal government website - www.Healthcare.gov - has tools to sign up for new coverage, change plans or renew coverage for
Medicare open enrollment, also called annual enrollment, has begun and continues through Dec. 7. During open enrollment, all Medicare participants have the opportunity to change Medicare plans or add or drop coverage. Outside of the open enrollment period, there are not many opportunities for current Medicare participants to change their coverage. Medicare plans may adjust which medications and
In recognition of Respiratory Care Week Oct. 21-27, the Pulmonary Hypertension Association (PHA) interviewed a registered respiratory therapist and certified pulmonary function technician. Tonya Zeiger, R.R.T., CPFT, is the pulmonary hypertension (PH) coordinator and associate in pulmonary medicine at the Mayo Clinic’s Jacksonville, Fla. campus, a PHA-accredited Center of Comprehensive Care (CCC). In this interview,
